Specifically, there were no significant differences in the primary measures of RA severity, the DAS28-CRP and the DAS28-ESR, suggesting that, on average, clinicians did not assign one drug to significantly ‘sicker’ patients. The gene discussed is CRP; the disease is rheumatoid arthritis.